Cargando…
A new strategy to target regulatory T cells in solid tumors
The depletion of regulatory T cells (Tregs) is a promising therapeutic strategy to enhance antitumor immune responses. Our recent findings indicate that low doses of arsenic trioxide can delay tumor growth in murine models of colon and breast cancer by depleting Tregs through oxidative and nitrosati...
Autores principales: | Thomas-Schoemann, Audrey, Batteux, Frédéric, Alexandre, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661163/ https://www.ncbi.nlm.nih.gov/pubmed/23802078 http://dx.doi.org/10.4161/onci.23338 |
Ejemplares similares
-
Extending the chimeric receptor-based T-cell targeting strategy to solid tumors
por: Rossig, Claudia
Publicado: (2013) -
Targeting the right regulatory T-cell population for tumor immunotherapy
por: Weiss, Vivian L., et al.
Publicado: (2012) -
The relationship between malignant and tumor-associated cells provides a new strategy for targeted diagnosis and therapy
por: Lu, Xiaoling, et al.
Publicado: (2013) -
DDR1 inhibition as a new therapeutic strategy for colorectal cancer
por: Sirvent, Audrey, et al.
Publicado: (2018) -
Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison
por: Conrad, Curdin, et al.
Publicado: (2013)